 | By CorporateAds NRx's HOPE Therapeutics is preparing to deploy Zeta Surgical's newly FDA-cleared robotic TMS technology in Florida, adding another major piece to a rapidly expanding neuropsychiatric platform while the company advances toward potential 2026...
|
 | By CorporateAds With revenue shifting rapidly beyond China, positive net income returning, new international registrations, an expanding U.S.
|
 | By Institute of Industrial & Systems Engineers While innovation in industries can lead to greater production and bottom lines, in healthcare it provides a more vital benefit: Better patient outcomes that save lives.
|
 | By CorporateAds Q2 update reinforces the central NRXP investment thesis: preservative-free ketamine is moving toward commercialization while NRX-101, DARPA funding, HOPE Therapeutics and a stronger balance sheet create multiple potential catalysts.
|
By Crossroads4Hope A national leader in comprehensive, no-cost supportive cancer care celebrates a milestone - and sets its sights on reaching more individuals and families
|
 | By CorporateAds First-cycle FDA review delivers one of the strongest signals yet that NRx's preservative-free ketamine opportunity may be entering its final stretch, while the company's broader neuropsychiatric pipeline continues to gain momentum.
|
 | By CorporateAds Today's Commercial Expansion, Growing Enterprise Deployments and Accelerating Merger Timeline Position MBody AI $MBAI to Capitalize on the Rapidly Emerging Multi-Trillion-Dollar Embodied AI Revolution
|
 | By CorporateAds Potential DARPA Award, FDA-Authorized Phase 2/3 Trial, Breakthrough Therapy NRX-101, and Robotic-Enabled TMS Platform Highlight Expanding Opportunities for NRx Pharmaceuticals, Inc. (N A S D A Q: NRXP)
|
 | By Cummings Graduate Institute Integrated Behavioral Health: Applying the Biodyne Model in Healthcare brings together more than 30 healthcare leaders to advance integrated care across clinical settings.
|
 | By CorporateAds First Commercial Deployment of FDA-Cleared AI-Guided TMS Navigation System, Expanded FDA Pathway for NRX-101, and Growing Commercial Infrastructure Highlight Accelerating Momentum for NRx Pharmaceuticals (N A S D A Q: NRXP)
|
 | By CorporateAds NRx's HOPE Therapeutics is preparing to deploy Zeta Surgical's newly FDA-cleared robotic TMS technology in Florida, adding another major piece to a rapidly expanding neuropsychiatric platform while the company advances toward potential 2026...
|
 | By CorporateAds With revenue shifting rapidly beyond China, positive net income returning, new international registrations, an expanding U.S.
|
By Vasaj Communications Founder & CEO of OptimaNova AI, Joe Paul, will be the speaker for an audience of senior healthcare executives during the Leverage Network Beyond Boundaries Program, on September 16 at 2:00 pm, at 444 W Lake Street, Suite 2500, Chicago.
|
By watchdoq Starting in Kolkata, Watchdoq is building a patient-first emergency platform to help families find appropriate care when time matters.
|
By Dev Technosys Empowering Patients and Providers Through Secure, Scalable, and Personalized Digital Healthcare Experiences
|
By FTS Cleanrooms FTS Cleanrooms has completed a 14,000 sqm turnkey cleanroom facility for Himalaya in Dubai, delivering the pharmaceutical and cosmetics manufacturing plant in under one year.
|
 | By Institute of Industrial & Systems Engineers While innovation in industries can lead to greater production and bottom lines, in healthcare it provides a more vital benefit: Better patient outcomes that save lives.
|
By Dev Technosys Dev Technosys strengthens its healthcare app development capabilities to deliver secure, scalable, and user-centric digital health solutions for modern healthcare businesses.
|
By ALMSCHC ALMS Community Health Center Highlights the Importance of Early and Preventive Care
|
 | By CorporateAds Q2 update reinforces the central NRXP investment thesis: preservative-free ketamine is moving toward commercialization while NRX-101, DARPA funding, HOPE Therapeutics and a stronger balance sheet create multiple potential catalysts.
|
By Crossroads4Hope A national leader in comprehensive, no-cost supportive cancer care celebrates a milestone - and sets its sights on reaching more individuals and families
|
By FTS Cleanroom UAE-based turnkey cleanroom engineering firm marks 17+ years in business with 1,000+ delivered projects spanning pharmaceutical, healthcare, and industrial cleanroom facilities across the Gulf, MENA, and Africa.
|
By Meditech Insights Patient Registry Software Market: Global Market Growth Study, Future Trends, Demands, and Top Players Data by Forecast to 2031
|
 | By CorporateAds First-cycle FDA review delivers one of the strongest signals yet that NRx's preservative-free ketamine opportunity may be entering its final stretch, while the company's broader neuropsychiatric pipeline continues to gain momentum.
|
 | By CorporateAds Today's Commercial Expansion, Growing Enterprise Deployments and Accelerating Merger Timeline Position MBody AI $MBAI to Capitalize on the Rapidly Emerging Multi-Trillion-Dollar Embodied AI Revolution
|
By The Health Pals Company LLC Henry C. Service, J.D. brings legal, regulatory and redevelopment experience to a community healthcare model serving underserved rural and urban areas.
|
By Clinaptis Advisors Report develops a reverse-solve valuation framework separating VK2735's subcutaneous valuation floor from the unresolved commercial opportunity of the oral obesity program.
|
By AGS Health AGS Health® a leading provider of tech-first revenue cycle management (RCM) solutions serving healthcare providers across the U.S.
|
By Dr. Heavenly for Georgia, LLC Physicians, Healthcare Experts, Insurance Professionals and Community Leaders to Discuss Practical Solutions to Improve Healthcare Access and Outcomes for Georgia Families
|
 | By CorporateAds Potential DARPA Award, FDA-Authorized Phase 2/3 Trial, Breakthrough Therapy NRX-101, and Robotic-Enabled TMS Platform Highlight Expanding Opportunities for NRx Pharmaceuticals, Inc. (N A S D A Q: NRXP)
|
By Meditech Insights The Global Stem Cells Market is projected to grow at a CAGR of approximately 9–12% through 2031, driven by increasing investments in regenerative medicine, expanding stem cell research, and the growing demand for advanced therapies to treat chronic and...
|
By PSIDispo Plasti Surge Industries Pvt. Ltd. (PSI Dispo), a trusted name in healthcare consumables and infection-control solutions, will take part in Medicall 2026, India's leading B2B medical equipment and healthcare exhibition, scheduled from 24th to 26th July...
|
By List2u.com LLC The company says modern healthcare growth requires connected systems that improve visibility, trust and market access before the first appointment.
|
By Logix Construction, LLC In today's business environment, sales leadership is no longer about managing salespeople. It is about building a predictable revenue engine. Says Jim Sayazdad
|
By Logix Construction, LLC Industry Expert Jim Sayadzad Highlights Emerging Trends Reshaping Sales Operations, Accountability, and Revenue Growth
|
 | By Cummings Graduate Institute Integrated Behavioral Health: Applying the Biodyne Model in Healthcare brings together more than 30 healthcare leaders to advance integrated care across clinical settings.
|
By Meals on Wheels South Florida Support Will Expand Senior Services and Deepen Community Impact
|
By Corvus Global Events Join healthcare leaders, pharma executives, providers, AI innovators, policymakers, health systems, and digital pioneers redefining healthcare delivery, patient outcomes, and intelligent systems.
|
 | By CorporateAds First Commercial Deployment of FDA-Cleared AI-Guided TMS Navigation System, Expanded FDA Pathway for NRX-101, and Growing Commercial Infrastructure Highlight Accelerating Momentum for NRx Pharmaceuticals (N A S D A Q: NRXP)
|
By Filos Health Laboratory Inc As healthcare barriers continue to affect millions of Americans, Filos Health is redefining patient access by bringing laboratory and diagnostic services directly to homes, workplaces, and communities nationwide.
|
By Meditech Insights The demand for oligonucleotide-based therapies is accelerating as biotech and pharmaceutical companies advance innovations in antisense oligonucleotides (ASOs), siRNA, microRNA, aptamers, and other nucleic acid therapeutics.
|